Navigation Links
Pharmaceutical Membrane Filtration Market by Product, Technique, Application - Global Forecast to 2021

NEW YORK, Feb. 1, 2017 /PRNewswire/ -- The global pharmaceutical membrane filtration market is expected to reach USD 6.20 billion by 2021 from USD 3.55 billion in 2016, at a CAGR of 11.8% from 2016 to 2021. Growth in the biopharmaceutical industry and advancements in the nanofiltration technology are the key factors driving the growth of the market. On the other hand, strict government regulations for validation of the filtration process and low adoption of membrane filters in emerging markets due to cost constraints are the major factors restraining the growth of this market

Factors such as increase in the growth of biopharmaceutical industry and rapid growth in generic drug production are driving the global pharmaceutical Filtration market. However stringent government regulations for validation of the filtration process hindering the growth of this market.

The global pharmaceutical membrane filtration market has been segmented on the basis of type of products, technique, application, and region.

On the basis of product, the pharmaceutical membrane filtration market is segmented into MCE membrane filters, coated cellulose acetate membrane filters, nylon membrane filters, PTFE membrane filters, PVDF membrane filters, and other membrane filters. The MCE membrane filters segment is expected to account for the largest and fastest-growing segment of the global pharmaceutical membrane filtration market in 2016. The large share of this segment is primarily attributed to the increasing adoption of different types of membrane filters for various filtration applications and the frequent use of these filters as compared to prefilters, single-use systems, and cartridges & capsules. The increasing focus of the pharmaceutical industries can also lead to the adoption rate of biopharmaceutical industry has resulted in the increase in demand for pharmaceutical membrane Filtration products.

Based on product, the pharmaceutical membrane filtration market is segmented into MCE, coated cellulose, nylon, PTFE membrane, PVDF membrane, other membrane. The MCE membrane product is estimated to witness the highest CAGR during the forecast period, 2016 to 2021. Due to high production of pharmaceutical products and drugs, MCE attributes the largest share.

Based on technique, the pharmaceutical membrane filtration market has beenis segmented into microfiltration, nano filtration, crossfiltration, ultrafiltration, reverse osmosis, and ion exchange. The microfiltration segment is anticipated expected to grow at the highest CAGR during the forecast period.from 2016 to 2021. The high adoption of microfiltration over other techniques in pharmaceutical applications accounts for the large share of this segment. The high growth in this segment is due to the rising demand the research and medical services.

On the basisBased on application, the global pharmaceutical membrane filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification, Processing, Raw material filtration. The final product processing segment is further classified into active pharmaceutical ingredient filtration, sterile filtration, protein purification, vaccine and & antibody processing, formulation and & filling solutions, and viral clearance. Among the applications, The final product processing segment is expected to witness the highest growth rate during the forecast period, due to advancement of Nano-filtration.

Geographically, the market is segmented into four regions, namely, North America, Europe, Asia, and RoW. and rest of the world (ROW). The global pharmaceutical membrane filtration market is dominated by North America, followed by Europe. The growth of this market is mainly driven by the growth in the pharmaceutical industry, increasing incidence of airborne disease, rapid expansion of generics production, and advancements in nanofiber technology.

Growth in the North American region is due to the increasing in incidence of airborne diseases which will boost the growth of this market. Also, R&D growth and spending on pharmaceutical and biotechnology projects and the rising number of drug development projects are important drivers for the pharmaceutical filtration market in North America. Besides this, the large size of the North American biotechnology industry is expected to continue to drive the growth of the pharmaceutical filtration market in this region.

The major players in the global pharmaceutical membrane filtration market include Merck KGaA (Germany), GE Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), and GEA Group (Germany).Merck KGaA (Germany), General Electric Company (U.S.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), ALFA LAVAL (Sweden), Graver Technologies, LLC (U.S.), Koch membrane system (U.S.), and GEA Group (Germany).

Research Coverage
This report aims to provide insights on the global pharmaceutical membrane filtration market. It provides valuable information on the type of product, technique, application, and regionsnal segments of the global pharmaceutical filtration market. The report also covers the market dynamics which includes the drivers, restraints, opportunities and challenges of the global pharmaceutical membrane filtration market. This report covers the competitive landscape of the top ten companies in the global pharmaceutical membrane filtration market. The competitive landscape includes a comparison between the companies and the strategies adopted by them in order to continue their presence in the Pharmaceutical membrane filtration market.

Value Addition for the Buyer:
The above mentioned information would benefit buyers by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years.

In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output, in order to remain successful in the global pharmaceutical membrane filtration market.

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare:
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:

SOURCE Reportlinker
Copyright©2017 PR Newswire.
All rights reserved

Related medicine technology :

1. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
2. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
3. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
4. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
5. Access Pharmaceuticals Reports First Quarter Results
6. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
7. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
8. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
9. Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
10. Aveo Pharmaceuticals, Inc. Sued by Investor
11. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
Post Your Comments:
(Date:8/28/2020)... ... 28, 2020 , ... Cano Health, LLC, a leading population ... San Antonio is happy to announce that it has selected Tejano musician Jay ... he will serve as community advisor, advertising talent, and creative consultant for Cano ...
(Date:8/27/2020)... ... ... Austin Oral Surgery – an oral and maxillofacial surgery practice with 11 locations ... joined the practice. An accomplished oral and maxillofacial surgeon, Dr. Szalay’s primary responsibility will ... this fall. The new office is slated for 1601 E. Pflugerville Parkway, Building 2; ...
(Date:8/27/2020)... (PRWEB) , ... August 27, 2020 , ... Bridge To ... Directors. Dr. Friedman is an adult and pediatric neuro-oncologist who serves on the Board ... as an educator at Duke University Medical School. , Internationally recognized, Dr. Friedman is ...
Breaking Medicine Technology:
(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the first ... Pediatric Feeding Disorder (PFD), is pleased to announce that the U.S. Centers for Disease ... (R code) in the next edition of the U.S. International Classification of Diseases ...
(Date:9/1/2020)... ... September 01, 2020 , ... Dr. Kiran Gill is a ... of the face, breast, and body. In 2018, she founded Aesthetics in Plastic ... and aesthetic practice in Southwest Florida. Dr. Gill and her team offer surgical ...
(Date:8/31/2020)... ... 31, 2020 , ... The Lymphoma Research Foundation (LRF) ... research and serving the lymphoma community through a comprehensive series of education programs, ... Cancer Awareness Month (BCAM) and its international Light it Red for Lymphoma ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... N95 face masks to medical first responders across the United States. Since the ... of personal protective equipment (PPE) medical centers , hospitals , ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... business management solution for chiropractors, announced today the launch of its integrated, HIPAA ... can start running their virtual practice in under 90 seconds. , According ...
Breaking Medicine News(10 mins):